Henrion R, Oury J F, Dumez Y, Ammous A, Vige P
J Gynecol Obstet Biol Reprod (Paris). 1984;13(8):939-46.
The authors have used suppositories containing 1 mg of an analogue of PGE1 in 117 cases. The indication was fetal abnormality or fetal disease in 85 cases, fetal death in utero in 24 cases and very premature rupture of the membranes in 8 cases. The pessaries have a number of advantages over the techniques that were employed previously; intra-amniotic injection and intra-cervical perfusion of PGF2. The method is very efficacious: 98.3% successes. There was no failure in the series of intra-uterine fetal deaths. Placing the pessaries in the posterior vaginal fornix is easy and the technique does not consist of any manipulation. Not having to put any laminary tents in and no early rupture of the membranes has made it possible to avoid infection except in 1.7% of cases. The incidence of heavy bleeding was exceptionally low: 0.8%. As far as the dangers of rupture of the uterus or of tears in the cervix, this was minimal. Picking cases for correct indications, using doses adapted to each patient and careful observation by a team who are used to dealing with terminations of pregnancy and their techniques should lower the risk. The time spent in hospital is lessened: on an average 3 days. The fetus that is expelled is never macerated, which is important in order to be able to find out all the facts necessary to give good genetic counselling to a couple who have been profoundly traumatised.(ABSTRACT TRUNCATED AT 250 WORDS)
作者在117例患者中使用了含1毫克前列腺素E1类似物的栓剂。其中85例的适应症为胎儿异常或胎儿疾病,24例为宫内死胎,8例为胎膜过早破裂。与先前采用的羊膜腔内注射和宫颈内灌注前列腺素F2的技术相比,该栓剂有许多优点。该方法非常有效:成功率为98.3%。在宫内死胎系列中无失败病例。将栓剂置于阴道后穹窿很容易,且该技术无需任何操作。无需放置任何阴道窥器且无胎膜早破,使得除1.7%的病例外可避免感染。大出血发生率极低:0.8%。至于子宫破裂或宫颈撕裂的风险,这是极小的。选择合适适应症的病例,使用适合每位患者的剂量,并由熟悉终止妊娠及其技术的团队进行仔细观察,应可降低风险。住院时间缩短:平均3天。排出的胎儿从未浸软,这对于能够为受到严重创伤的夫妇提供良好遗传咨询所需的所有事实至关重要。(摘要截短至250字)